ProPhase Labs (PRPH) Company Cash Funds

ProPhase Labs, Inc. (PRPH) focuses on the express delivery of biomaterials to laboratories, combining diagnostics with the sale of dietary supplements. However, the decline in COVID-related revenues forced the company to implement genomic testing during a period of structural crisis. This cash balance chart illustrates the issuer's defensive potential, with the 0.00 mark serving as the current indicator of the business's liquid reserves.
Analytical breakdowns for ProPhase Labs (PRPH)

A fundamental valuation of ProPhase Labs, Inc. (PRPH) requires a liquidity analysis to confirm the company's ability to maintain its costly molecular genetic laboratory infrastructure in New York. The company's cash dynamics reflect the volume of free cash flow on the balance sheet, allowing investors to assess the issuer's financial autonomy and its readiness to cover operational expenses for power supply and clean room climate control without incurring external debt.